This review - which includes a moderate level of technical detail - covers both the progress of microbicides through laboratory and clinical testing, and the social science and market research that supports microbicides as an HIV prevention option.

Particularly useful is the brief information it provides on which companies are developing each product, and the locations of clinical trials. However, it lacks the illustrations and graphic design of other reviews of microbicide development.

Go to key document